Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department

NCT07667621 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.

NCT NCT07667621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07667621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open-Label Study Evaluating the Effectiveness of Rimegepant ODT or Zavegepant Nasal Spray for Acute Treatment of Migraine in the Emergency Department
Lead sponsor
University of South Florida
Phase
Phase 1
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
August 31, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine, migraine, migraine disease, migraine headache, migraine in adults, migraine with aura, migraine without aura